Related references
Note: Only part of the references are listed.Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+Cell Infection
Nancie M. Archin et al.
PLOS ONE (2010)
Short Communication: Activation of Latent HIV Type 1 Gene Expression by Suberoylanilide Hydroxamic Acid (SAHA), an HDAC Inhibitor Approved for Use to Treat Cutaneous T Cell Lymphoma
Leonard C. Edelstein et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid
Nancie M. Archin et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells
Alberto Bosque et al.
BLOOD (2009)
Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells
Xavier Contreras et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The CXCR4-Tropic Human Immunodeficiency Virus Envelope Promotes More-Efficient Gene Delivery to Resting CD4+ T Cells than the Vesicular Stomatitis Virus Glycoprotein G Envelope
Luis M. Agosto et al.
JOURNAL OF VIROLOGY (2009)
The HIV Envelope but Not VSV Glycoprotein Is Capable of Mediating HIV Latent Infection of Resting CD4 T Cells
Dongyang Yu et al.
PLOS PATHOGENS (2009)
Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells
Nancy M. Archin et al.
AIDS (2008)
HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration
Luis M. Agosto et al.
VIROLOGY (2007)
Stability of the latent reservoir for HIV-1 in patients receiving valproic acid
Janet D. Siliciano et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1
Samuel A. Williams et al.
JOURNAL OF VIROLOGY (2007)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
Human immunodeficiency virus type 1 latency model for high-throughput screening
S Micheva-Viteva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli
WJ Swiggard et al.
JOURNAL OF VIROLOGY (2005)
Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
G Lehrman et al.
LANCET (2005)
The IKK/NF-κB activation pathway -: a target for prevention and treatment of cancer
FR Greten et al.
CANCER LETTERS (2004)
A new cell-permeable peptide allows successful allogeneic islet transplantation in mice
H Noguchi et al.
NATURE MEDICINE (2004)
Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals
JM Fondere et al.
JOURNAL OF VIROLOGY (2004)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
Host cell gene expression during human immunodeficiency virus type I latency and reactivation and effects of targeting genes that are differentially expressed in viral latency
V Krishnan et al.
JOURNAL OF VIROLOGY (2004)
Prostratin antagonizes HIV latency by activating NF-κB
SA Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression
L Ylisastigui et al.
AIDS (2004)
To be, or not to be:: NF-κB is the answer -: role of Rel/NF-κB in the regulation of apoptosis
J Kucharczak et al.
ONCOGENE (2003)
Identification of T cell-signaling pathways that stimulate latent HIV in primary cells
DG Brooks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo
M Hermankova et al.
JOURNAL OF VIROLOGY (2003)
Effects of prostratin on T-cell activation and human immunodeficiency virus latency
YD Korin et al.
JOURNAL OF VIROLOGY (2002)
Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)
HJ Stellbrink et al.
AIDS (2002)
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection
M Dybul et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
M Göttlicher et al.
EMBO JOURNAL (2001)
OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+T cell depletion
RME Van Praag et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2001)
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy
TW Chun et al.
NATURE MEDICINE (2000)
Share Paper
